This correlation proposed that the elevated CTRP3 levels in T2D could be a compensatory mechanism developed in long standing DM to decrease the state of hyperglycemia through altering the increased insulin resistance (IR) and decreased insulin sensitivity (measured by QUICKI) present in these patients. Here, C1QTNF3 is linked to Insulin resistance.